Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Block Listing Application

8 Mar 2016 09:00

RNS Number : 2351R
Premier Veterinary Group PLC
08 March 2016
 

 

 

 

BLOCK LISTING APPLICATION

 

 

London, 8 March 2016: Premier Veterinary Group plc (LSE: PVG) (the "Company") announces that it has made a block listing application to the London Stock Exchange for the admission of up to 1,674,212 ordinary shares of 10 pence each to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities.

 

The block listing application relates to the following:

 

Warrants

 

As part of the arrangements relating to the reverse acquisition by the Company of Premier Veterinary Group Limited (now PVG 2007 Limited) completed in February 2015, warrants were granted over 279,034 ordinary shares of 10 pence each, vesting and becoming exercisable in two equal tranches on 27 February 2016 and 27 February 2017 respectively.

The block listing application is for the total number of shares that could be issued pursuant to the exercise of all of those warrants, representing approximately 2% of the current issued share capital. The application for the admission of these shares has been made in advance for ease of administration.

Further information relating to the warrants can be found in the Company's Annual Report and Accounts 2015 available on its website: www.premiervetgroup.co.uk.

Share options

 

The block listing application also includes a further 1,395,178 shares, being the total number of shares that could be issued pursuant to the exercise of all options currently outstanding under the 2014 Ark Therapeutics Group plc Enterprise Management Incentive Share Option Plan (the "EMI Plan"). If all the options were exercised, the shares that would be issued would represent approximately 10% of the current issued share capital.

The application for the admission of these shares has been made in advance for ease of administration as all the outstanding options under the EMI Plan vested and became exercisable on 27 February 2016.

 

 

Shares issued pursuant to the exercise of the warrants and the options under the EMI Plan will rank pari passu with the existing ordinary shares of 10 pence each in the share capital of the Company.

 

It is expected that the block admission will become effective on 9 March 2016.

 

 

Enquiries:

 

Premier Veterinary Group plc

Sue Steven, Company Secretary +44 (0)117 370 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISSSFSUWFMSELD
Date   Source Headline
2nd Jun 20154:55 pmRNSChange of Auditor
29th May 20157:00 amRNSHalf Yearly Report
7th May 20153:42 pmRNSChange of Registered Office
29th Apr 20157:01 amRNSTrading Statement
29th Apr 20157:00 amRNSFinal Results
13th Mar 201511:22 amRNSHolding(s) in Company
9th Mar 20157:00 amRNSRenamed Premier Veterinary Group
3rd Mar 201512:33 pmRNSHolding(s) in Company
3rd Mar 20159:48 amRNSHolding(s) in Company
2nd Mar 20152:36 pmRNSHolding(s) in Company
2nd Mar 201510:55 amRNSHolding(s) in Company
2nd Mar 201510:42 amRNSHolding(s) in Company
27th Feb 20154:35 pmRNSPrice Monitoring Extension
27th Feb 20154:07 pmRNSBoard Changes and Directors' Dealings
27th Feb 20158:00 amRNSCancellation
27th Feb 20157:00 amRNSAdmission to the Official List
26th Feb 20154:00 pmRNSCancellation and Publication of Prospectus
5th Feb 20154:22 pmRNSAcquisition completed
28th Jan 20159:29 amRNSSale and Purchase Agreement Signed
15th Jan 20157:00 amRNSTransfer of listing category on the Official List
4th Dec 201411:17 amRNSBlocklisting Interim Review
21st Nov 20145:48 pmRNSPosting of Circular
1st Aug 20147:00 amRNSHalf Yearly Report and Change of Registered Office
1st Jul 20147:00 amRNSResults of AGM and Board Changes
3rd Jun 20147:00 amRNSBlocklisting Interim Review
13th May 20147:00 amRNSInterim Management Statement
30th Apr 20147:00 amRNSFinal Results
28th Mar 20147:45 amRNSSuspension - Ark Therapeutics Group Plc
28th Mar 20147:32 amRNSSigned Heads of Terms and Suspension of Trading
25th Mar 201412:48 pmRNSHolding(s) in Company
4th Mar 201412:22 pmRNSHolding(s) in Company
21st Feb 20144:40 pmRNSSecond Price Monitoring Extn
21st Feb 20144:35 pmRNSPrice Monitoring Extension
20th Feb 201410:44 amRNSHolding(s) in Company
20th Feb 201410:39 amRNSHolding(s) in Company
20th Feb 201410:38 amRNSHolding(s) in Company
6th Dec 20135:46 pmRNSBlocklisting Interim Review
6th Nov 20137:00 amRNSInterim Management Statement
8th Oct 201311:27 amRNSHolding(s) in Company
7th Oct 20134:35 pmRNSPrice Monitoring Extension
7th Oct 20133:21 pmRNSHolding(s) in Company
27th Sep 201311:46 amRNSHolding(s) in Company
26th Sep 20133:26 pmRNSHolding(s) in Company
24th Sep 201311:02 amRNSHolding(s) in Company
20th Sep 201311:47 amRNSHolding(s) in Company
18th Sep 20134:40 pmRNSSecond Price Monitoring Extn
18th Sep 20134:35 pmRNSPrice Monitoring Extension
17th Sep 201310:00 amRNSHolding(s) in Company
13th Sep 201311:40 amRNSHolding(s) in Company
10th Sep 201310:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.